vs
Side-by-side financial comparison of GYRE THERAPEUTICS, INC. (GYRE) and Plymouth Industrial REIT, Inc. (PLYM). Click either name above to swap in a different company.
Plymouth Industrial REIT, Inc. is the larger business by last-quarter revenue ($51.2M vs $37.2M, roughly 1.4× GYRE THERAPEUTICS, INC.). GYRE THERAPEUTICS, INC. runs the higher net margin — -3.7% vs -106.3%, a 102.6% gap on every dollar of revenue. On growth, GYRE THERAPEUTICS, INC. posted the faster year-over-year revenue change (33.4% vs -1.4%). Over the past eight quarters, GYRE THERAPEUTICS, INC.'s revenue compounded faster (17.0% CAGR vs 0.4%).
GYRE Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing novel targeted therapies for hard-to-treat hematologic malignancies and solid tumors. It focuses on precision oncology to address unmet patient needs, with operations primarily based in North America.
Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.
GYRE vs PLYM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $37.2M | $51.2M |
| Net Profit | $-1.4M | $-54.4M |
| Gross Margin | 95.3% | — |
| Operating Margin | 0.3% | -102.5% |
| Net Margin | -3.7% | -106.3% |
| Revenue YoY | 33.4% | -1.4% |
| Net Profit YoY | -340.1% | -248.5% |
| EPS (diluted) | $-0.01 | $-1.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $37.2M | — | ||
| Q3 25 | $30.6M | $51.2M | ||
| Q2 25 | $26.8M | $47.2M | ||
| Q1 25 | $22.1M | $45.6M | ||
| Q4 24 | $27.9M | $47.6M | ||
| Q3 24 | $25.5M | $51.9M | ||
| Q2 24 | $25.2M | $48.7M | ||
| Q1 24 | $27.2M | $50.2M |
| Q4 25 | $-1.4M | — | ||
| Q3 25 | $5.9M | $-54.4M | ||
| Q2 25 | $1.6M | $-6.1M | ||
| Q1 25 | $3.7M | $5.8M | ||
| Q4 24 | $569.0K | $147.4M | ||
| Q3 24 | $2.9M | $-15.6M | ||
| Q2 24 | $4.5M | $1.3M | ||
| Q1 24 | $9.9M | $6.2M |
| Q4 25 | 95.3% | — | ||
| Q3 25 | 94.7% | — | ||
| Q2 25 | 95.7% | — | ||
| Q1 25 | 95.9% | — | ||
| Q4 24 | 95.8% | — | ||
| Q3 24 | 96.2% | — | ||
| Q2 24 | 96.9% | — | ||
| Q1 24 | 96.4% | — |
| Q4 25 | 0.3% | — | ||
| Q3 25 | 22.7% | -102.5% | ||
| Q2 25 | 8.1% | -10.3% | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 16.6% | -29.6% | ||
| Q2 24 | 12.7% | 2.7% | ||
| Q1 24 | 29.7% | — |
| Q4 25 | -3.7% | — | ||
| Q3 25 | 19.4% | -106.3% | ||
| Q2 25 | 5.9% | -12.9% | ||
| Q1 25 | 16.9% | 12.8% | ||
| Q4 24 | 2.0% | 309.9% | ||
| Q3 24 | 11.2% | -30.1% | ||
| Q2 24 | 18.0% | 2.7% | ||
| Q1 24 | 36.6% | 12.4% |
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $0.03 | $-1.23 | ||
| Q2 25 | $0.00 | $-0.14 | ||
| Q1 25 | $0.00 | $0.13 | ||
| Q4 24 | $0.00 | $3.24 | ||
| Q3 24 | $0.01 | $-0.35 | ||
| Q2 24 | $0.01 | $0.03 | ||
| Q1 24 | $0.03 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $52.4M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $106.0M | $470.1M |
| Total Assets | $166.1M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.4M | — | ||
| Q3 25 | $60.0M | — | ||
| Q2 25 | $54.4M | — | ||
| Q1 25 | $29.9M | — | ||
| Q4 24 | $26.7M | — | ||
| Q3 24 | $25.1M | — | ||
| Q2 24 | $25.1M | — | ||
| Q1 24 | $37.4M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $646.4M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $106.0M | — | ||
| Q3 25 | $101.9M | $470.1M | ||
| Q2 25 | $92.0M | $539.6M | ||
| Q1 25 | $68.1M | $571.0M | ||
| Q4 24 | $63.3M | $579.5M | ||
| Q3 24 | $63.2M | $436.5M | ||
| Q2 24 | $60.4M | $475.2M | ||
| Q1 24 | $56.6M | $484.6M |
| Q4 25 | $166.1M | — | ||
| Q3 25 | $159.4M | $1.6B | ||
| Q2 25 | $152.6M | $1.6B | ||
| Q1 25 | $129.8M | $1.4B | ||
| Q4 24 | $125.4M | $1.4B | ||
| Q3 24 | $125.2M | $1.5B | ||
| Q2 24 | $120.9M | $1.4B | ||
| Q1 24 | $122.0M | $1.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.6M | $20.0M |
| Free Cash FlowOCF − Capex | $-5.8M | — |
| FCF MarginFCF / Revenue | -15.5% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-180.0K | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-5.6M | — | ||
| Q3 25 | $4.7M | $20.0M | ||
| Q2 25 | $2.1M | $23.4M | ||
| Q1 25 | $-129.0K | $15.6M | ||
| Q4 24 | $-2.8M | $96.1M | ||
| Q3 24 | $1.7M | $17.6M | ||
| Q2 24 | $-5.5M | $19.9M | ||
| Q1 24 | $2.9M | $16.6M |
| Q4 25 | $-5.8M | — | ||
| Q3 25 | $4.0M | — | ||
| Q2 25 | $1.8M | — | ||
| Q1 25 | $-251.0K | — | ||
| Q4 24 | $-2.8M | — | ||
| Q3 24 | $1.0M | — | ||
| Q2 24 | $-6.9M | — | ||
| Q1 24 | $2.7M | — |
| Q4 25 | -15.5% | — | ||
| Q3 25 | 13.1% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | -1.1% | — | ||
| Q4 24 | -10.1% | — | ||
| Q3 24 | 4.1% | — | ||
| Q2 24 | -27.5% | — | ||
| Q1 24 | 9.8% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 2.2% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.2% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 5.8% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.79× | — | ||
| Q2 25 | 1.32× | — | ||
| Q1 25 | -0.03× | 2.67× | ||
| Q4 24 | -4.85× | 0.65× | ||
| Q3 24 | 0.60× | — | ||
| Q2 24 | -1.21× | 15.12× | ||
| Q1 24 | 0.29× | 2.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
